Livzon Pharmaceutical Group (HK:1513) has released an update. Livzon Pharmaceutical Group has announced the proposed election of Mr. Lin Nanqi as a non-executive director, pending shareholder ...

Livzon Pharmaceutical Group (HK:1513) has released an update. Livzon Pharmaceutical Group Inc. has announced its 2024 third extraordinary general meeting set for November 26, aiming to approve a ...

Livzon Pharmaceutical Group (HK:1513) has released an update. Livzon Pharmaceutical Group’s financial report for the third quarter of 2024 reveals a slight decline in operating income by 5.59% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Heeger, and company Zhuhai Livzon Diagnostics, one of China’s first in vitro diagnostic products manufacturing enterprises. Powered by this legacy, Sanmed Biotech aims to leverage its expertise ...

KINGKEY FIN INT Announcements and Notices - (Other - Miscellaneous) 01477 OCUMENSION-B Next Day Disclosure Returns - (Share Buyback) 01513 LIVZON PHARMA Next Day Disclosure Returns - (Share Buyback / ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...